Skip to content

Product1 publisher2 min readPublished

Ellison cancels a 50-million-share Oracle plan one day after US rules made it public

No shares changed hands, and the plan only became public because American filing rules require it. The facts that would have surfaced under any disclosure regime are Oracle's shrinking gross margins and a $2.8B charge for job cuts.

The Product Desk · Product desk

Photograph accompanying Ellison cancels a 50-million-share Oracle plan one day after US rules made it public
Photo: thenextweb.com

What happened

  • Larry Ellison cancelled a Rule 10b5-1 plan that would have let him sell up to 50 million Oracle shares by 24 October, a day after the plan was disclosed and with no stock sold under it.
  • The plan was adopted on 22 June, when the shares it covered were worth about $8.75B; after a 16% fall in the stock, the same block is worth about $7.5B.
  • Oracle reported shrinking gross margins on Thursday and raised the cost of its job cuts to $2.8B in the same week the plan surfaced.
  • Under the EU Market Abuse Regulation, managers cannot deal in the 30 calendar days before an interim or year-end report, and only executed trades get published, within three working days of each deal.
  • Ellison is Oracle's executive chair and chief technology officer, and he controls about 40% of the company.

Compiled by The Product DeskSomething wrong?How this is made

Why it matters

  • constraint A customer who runs the same insider check on a US filer and an EU filer gets two different answers, and what produces the difference is the disclosure regime.
  • decision For a team weighing an Oracle renewal, there is nothing in a cancelled plan to price. The charge for job cuts is another matter: money that size comes out of headcount, and some of that headcount sits on customer accounts.
  • exposure Anyone holding a multi-year Oracle commitment carries counterparty risk against a supplier The Next Web places one notch above junk, and that risk sits in the contract.

A team with an Oracle renewal open on the desk read a headline about 50 million shares this week and had to work out whether it changed anything they had signed. It does not.

A 10b5-1 plan is a timetable for future sales. An executive who adopts one while not holding inside information can let trades execute later on a fixed schedule, including in periods when selling at their own discretion would draw questions [10]. The rule dates from 2000, and the SEC tightened what has to be disclosed about these plans in 2022 [11].

The two totals divide into per-share prices of about $175 at adoption and about $150 now [1]. That works out at a fall of roughly 14%, slightly under the 16% The Next Web gives for the stock, and the difference is rounding in both totals [2].

Rule 10b5-1 is an American safe harbour with no European counterpart [17]. Europe would have recorded nothing here, because the plan never traded [14]. The Next Web wrote that the plan was disclosed exactly as American rules require, which is the only reason anybody knew about it, and that none of it suggests Ellison did anything improper [15]. Bloomberg reported the cancellation [2].

For anyone running vendor reviews across listings, the practical difference is what shows up and when. Europe publishes executed deals, once EUR 5,000 of them has been reached in a calendar year [13].

Judge a signal like this one on two things: whether the fact would be public if the vendor filed in Frankfurt instead of New York, and whether it changes what the vendor can deliver on the contract you hold. This plan is public only because Oracle files in New York, and it changes nothing Oracle can deliver. Oracle's 1.7% fall on Friday [8] moves no capacity and no support queue either.

The filing here is a document that exists because of where Oracle lists.

The Next Web's account links the timing to Oracle's margins, its charge for job cuts and its credit standing [18]. Oracle said: "No Oracle stock was sold under that plan, and he has no other plans to sell any of his Oracle stock" [3].

What to watch

  • Whether Ellison adopts a replacement plan, and how close to Oracle's next reporting date it would run.
  • Whether Oracle breaks out where the cost of its job cuts lands by function in its next filing.
  • Whether the gross margin line thins again at the next quarter.
Loading claim ledger
Loading source directory links
Loading share composer
Loading topic controls
Loading related stories